Medical Ikkou Group Co (TSE:3353) EBITDA per Share: 円789.41 (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3353 Medical Ikkou Group Co Ltd TSE:3353
63 GF Score
Price 円2,848.00
GF Value 円3,535.59
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medical Ikkou Group Co EBITDA per Share?

Medical Ikkou Group Co TSE:3353 +1.14% 63 EBITDA per Share is 円789.41 as of Feb. 2026. GuruFocus rates TSE:3353 with a GF Score™ of 63/100 and a GF Value™ of 円3,535.59 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 486 Conglomerates companies, Medical Ikkou Group Co ranks better than 56.38% on this metric.

Medical Ikkou Group Co's EBITDA per Share for the six months ended in Feb. 2026 was 円394.82. Its EBITDA per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円789.41.

During the past 12 months, the average EBITDA per Share Growth Rate of Medical Ikkou Group Co was 8.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 10.40% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 5.00% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Medical Ikkou Group Co's EBITDA per Share or its related term are showing as below:

TSE:3353' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -5.4   Med: 4.3   Max: 10.7
Current: 10.4

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Medical Ikkou Group Co was 10.70% per year. The lowest was -5.40% per year. And the median was 4.30% per year.

TSE:3353's 3-Year EBITDA Growth Rate is ranked better than
56.38% of 486 companies
in the Conglomerates industry
Industry Median: 6.85 vs TSE:3353: 10.40

Medical Ikkou Group Co's EBITDA for the six months ended in Feb. 2026 was 円1,487 Mil.

During the past 12 months, the average EBITDA Growth Rate of Medical Ikkou Group Co was 8.90% per year. During the past 3 years, the average EBITDA Growth Rate was 10.40% per year. During the past 5 years, the average EBITDA Growth Rate was 5.00% per year. During the past 10 years, the average EBITDA Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Medical Ikkou Group Co was 19.30% per year. The lowest was -5.90% per year. And the median was 7.70% per year.


Medical Ikkou Group Co  (TSE:3353) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Medical Ikkou Group Co EBITDA per Share Related Terms


Medical Ikkou Group Co EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Medical Ikkou Group Co's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Ikkou Group Co EBITDA per Share Chart

Medical Ikkou Group Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 640.36 587.21 665.40 725.76 789.51

Medical Ikkou Group Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.01 403.12 322.75 394.59 394.82
TSE:3353
63GF Score
Medical Ikkou Group Co Ltd TSE:3353
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Ikkou Group Co EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medical Ikkou Group Co's EBITDA per Share for the fiscal year that ended in Feb. 2026 is calculated as

EBITDA per Share(A: Feb. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=2971.724/3.764
=789.51

Medical Ikkou Group Co's EBITDA per Share for the quarter that ended in Feb. 2026 is calculated as

EBITDA per Share(Q: Feb. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=1486.875/3.766
=394.82

EBITDA per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円789.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of 円789.41 mean?
Medical Ikkou Group Co (TSE:3353) has a EBITDA per Share of 円789.41 as of Feb. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Medical Ikkou Group Co and its competitors. According to the industry distribution chart, Medical Ikkou Group Co ranks #212 out of 486 companies in the Conglomerates industry, placing it in the top 43.6%.
Is Medical Ikkou Group Co's EBITDA per Share too high?
Medical Ikkou Group Co's current EBITDA per Share is 円789.41. Based on the distribution chart, Medical Ikkou Group Co ranks #212 out of 486 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's EBITDA per Share compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #212 out of 486 companies for EBITDA per Share. This puts Medical Ikkou Group Co in the upper half of its industry. The industry median EBITDA per Share is 6.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Conglomerates company?
The median EBITDA per Share among Conglomerates companies is 6.85, based on 486 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median EBITDA per Share is 6.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current EBITDA per Share is 円789.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,535.59, compared to a current price of 円2,848.00 — trading 19.4% below its estimated fair value. The current EBITDA per Share is 円789.41. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current EBITDA per Share is 円789.41 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued. The current stock price of 円2,848.00 is trading 19.4% below its estimated GF Value™ of 円3,535.59. GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.

Key valuation signals for TSE:3353:

  • EBITDA per Share: 円789.41
  • GF Value™: 円3,535.59 vs. price of 円2,848.00 (19.4% below fair value)
  • GF Score™: 63/100 with 1 warning sign

No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Ikkou Group Co Business Description

Address 501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score

Get the complete analysis for TSE:3353

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,848.00
Price
円3,535.59
GF Value